How Small Biotechs Can Operate Like Big Pharma Without Big Pharma Budgets

Scientific breakthroughs in oncology, rare diseases, cell and gene therapies, immunology and precision medicine are increasingly being driven by agile...

Continue reading

25 Years of Navitas Industry Networks Through 25 Voices of Peer Leadership

25 Years in 25 Voices of Peer Leadership For 25 years, the forums and peer networks powered by Navitas Life Sciences have brought together pharmaceuti...

Continue reading

Advancing Parkinson’s Disease Research Through Smarter Clinical Trial Partnerships

How Foundations, Biotech and Pharma Organizations Can Accelerate Parkinson’s Studies with the Right Clinical Research Partner Parkinson’...

Continue reading

Why End-to-End Clinical Trial Solutions Are Becoming Critical for Global Drug Development

How integrated clinical, regulatory, pharmacovigilance and data science ecosystems are accelerating global development programs Insights ahead of the ...

Continue reading

5 Mistakes Biotech Companies Make When Choosing a CRO

Selecting the right clinical research organization (CRO) can determine the success or failure of a biotech company’s clinical program. With inc...

Continue reading

R Programming in the Age of AI: A Pharmaverse Webinar

The conversation around R programming has fundamentally changed. What was once viewed as a niche statistical language, largely confined to academia, h...

Continue reading

SAHPRA Update: pharmaREADY® for eCTD Submissions

SAHPRA Application ID Update 2025: Impact on eCTD Submission and eCTD Publishing The South African Health Products Regulatory Authority (SAHPRA) relea...

Continue reading

The History of Navitas Networks: From a simple platform to the 25th Anniversary

In 2001, a small group of life sciences leaders came together with a simple but unconventional idea, to create a space where industry peers could coll...

Continue reading

From Clinical Safety to Commercial Readiness: A Pharmacovigilance-in-a-Box Solution

Organizations approaching regulatory approval and commercialization face a rapid expansion in pharmacovigilance requirements, moving from development-...

Continue reading

How Navitas’ Ophthalmology Clinical Trials Are Solving Biotech Challenges

Biotech Innovation Meets Clinical Trial Excellence Biotech innovation is advancing rapidly but translating breakthroughs into approved therapies remai...

Continue reading

The Data Backbone of Hybrid Clinical Trials

Turning Regulatory Complexity into Strategic Advantage Hybrid and decentralized models are becoming the default architecture for modern clinical devel...

Continue reading

Real world Evidence Solutions for Foundations

Real-world evidence (RWE) is emerging as a cornerstone of modern clinical development and regulatory strategy for patient-centric innovation. How is r...

Continue reading

Navitas Earns EcoVadis Award for Second Year in a Row

Navitas has been awarded the EcoVadis Bronze Medal for the second consecutive year, showcasing the organization’s commitment to Environmental, ...

Continue reading

Key Changes in EU Pharmacovigilance Regulation 2025/1466 for MAHs

Understanding Commission Implementing Regulation (EU) 2025/1466 and Pharmacovigilance in 2026 and Beyond Commission Implementing Regulation (EU) 2025/...

Continue reading

Key Insights from PHUSE APAC Connect 2026

PHUSE APAC Connect 2026 brought together clinical data leaders, programmers and statisticians from across the region, and Navitas Life Sciences was pr...

Continue reading

Data Management in Clinical Trials with AI Automation

What Is Data Management in Clinical Trials? Data management in clinical trials is the structured process of collecting, validating, cleaning, standard...

Continue reading

What the Clinical Trial Industry Must Do by 2036

The biopharmaceutical industry is approaching a defining moment. Scientific breakthroughs across cell and gene therapies, precision oncology and novel...

Continue reading

Top 10 Advantages of Using Navitas Advisory Services in Pharma and Biotech

In an industry defined by scientific complexity, global regulatory shifts and rising expectations for speed and quality, pharma and biotech organizati...

Continue reading

How Foundations Can Build Efficient, Patient-Centric Clinical Registries

Patient registries have become one of the most powerful tools Foundations can use to advance research, improve care and amplify the patient voice. The...

Continue reading

Leveraging AI in Labeling

From Regulatory Necessity to Strategic Advantage AI in Labeling is emerging as an important milestone. After all, labeling has long been one of the mo...

Continue reading

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us